The Efficacy and Safety of Triple Therapy of Telmisartan/Amlodipine/Rosuvastatin
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 252 participants.
Also called NCT03860220
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 252 participants
- Sponsor
- Hyo-Soo Kim
- Registry
-
NCT03860220
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT03860220. Randomized; no masking; primary purpose treatment. Start 2019-04-25 (actual); primary completion 2023-09-07 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Efficacy and Safety of Triple Therapy of Telmisartan/Amlodipine/Rosuvastatin
- Condition
- Hypertension
- Condition
- Dyslipidemias
- Intervention (Drug)
- NEWSTATIN TS
- Intervention (Drug)
- CADUET
- Lead sponsor
- Hyo-Soo Kim
Record details
- Record id
cardio:ct-nct03860220- Content hash
2ef31820bf182623cab5d849070a018ef559ed3f093675a097a8fb0a52ca430f